Przegląd Dermatologiczny

Abstract

4/2018 vol. 105
Case report

Lupoid mucocutaneous leishmaniasis

Dermatol Rev/Przegl Dermatol 2018, 105, 534–541
Online publish date: 2018/09/06
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Introduction

Leishmaniasis is a parasitic infection caused by different species of the intracellular protozoan Leishmania and transmitted through the bite of an infected female sand fly. It occurs in various clinical forms, including cutaneous manifestations.

Objective

To present a case of lupoid mucocutaneous leishmaniasis in a patient from Ethiopia.

Case Report

A 17-year-old man with no significant medical history presented with papular, plaque and ulcerative lesions in the central region of face that had been present for one year. A smear followed by Giemsa stain revealed the presence of amastigotes in monocytes and extracellular matrix. Based on the clinical manifestation and microscopic examination, the diagnosis of mucocutaneous leishmaniasis was established. The treatment was based on N-methylglucamine antimoniate, with subsequent resolution of skin lesions.

Conclusions

Mucocutaneous leishmaniasis, including the lupoid subtype, is an important clinical entity in endemic areas. Treatment with antimony derivatives may be beneficial in affected subjects.

Share
without publication fees
without publication fees